CNS Delivery Via Adsorptive Transcytosis
Доставка в центральную нервную систему посредством адсорбтивного трансцитоза
2008-08-25
SCID: 54.1/j2g96mtr
Discuss with AI
adsorptive-mediated transcytosisblood-brain barrierbrain drug deliverycationic proteinscell-penetrating peptides
Figures from the paper
Abstract (AI)
Adsorptive-mediated transcytosis (AMT) provides a means for brain delivery of medicines across the blood-brain barrier (BBB). The BBB is readily equipped for the AMT process: it provides both the potential for binding and uptake of cationic molecules to the luminal surface of endothelial cells, and then for exocytosis at the abluminal surface. The transcytotic pathways present at the BBB and its morphological and enzymatic properties provide the means for movement of the molecules through the endothelial cytoplasm. AMT-based drug delivery to the brain was performed using cationic proteins and cell-penetrating peptides (CPPs). Protein cationization using either synthetic or natural polyamines is discussed and some examples of diamine/polyamine modified proteins that cross BBB are described. Two main families of CPPs belonging to the Tat-derived peptides and Syn-B vectors have been extensively used in CPP vector-mediated strategies allowing delivery of a large variety of small molecules as well as proteins across cell membranes in vitro and the BBB in vivo. CPP strategy suffers from several limitations such as toxicity and immunogenicity--like the cationization strategy--as well as the instability of peptide vectors in biological media. The review concludes by stressing the need to improve the understanding of AMT mechanisms at BBB and the effectiveness of cationized proteins and CPP-vectorized proteins as neurotherapeutics.
Key Findings
1
AMT strategies based on protein cationization and CPPs face toxicity, immunogenicity, and peptide instability in biological media.
2
Adsorptive-mediated transcytosis can enable brain delivery across the BBB through cationic molecule binding, endothelial uptake, intracellular transport, and abluminal exocytosis.
3
Cationized proteins modified with synthetic or natural polyamines have been shown to cross the BBB and support AMT-based drug delivery.
4
Further understanding of BBB AMT mechanisms and improved efficacy of cationized or CPP-vectorized proteins are needed for neurotherapeutic development.
5
Tat-derived and Syn-B cell-penetrating peptides facilitate delivery of diverse small molecules and proteins across cell membranes in vitro and the BBB in vivo.
Research Object
adsorptive-mediated transcytosis-based delivery of cationized proteins and cell-penetrating peptide vectors across the blood-brain barrier into the central nervous system
Research Subject
the mechanisms, BBB transport pathways, and delivery effectiveness, along with the toxicity, immunogenicity, and biological instability limitations, of AMT-based neurotherapeutic delivery
Publication Details
Publication Date
2008-08-25
Journal
Publisher
ISSN
Cited by
676
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest